Biogenic Fabrication of Iron/Iron Oxide Nanoparticles and Their Application

Overview

Journal Nanoscale Res Lett

Publisher Springer

Specialty Biotechnology

Date 2016 Nov 13

PMID 27837567

Citations 27

Authors

Khwaja Salahuddin Siddiqi

Aziz Ur Rahman

Tajuddin

Azamal Husen

Affiliations

Soon will be listed here.

Abstract

Enshrined in this review are the biogenic fabrication and applications of coated and uncoated iron and iron oxide nanoparticles. Depending on their magnetic properties, they have been used in the treatment of cancer, drug delivery system, MRI, and catalysis and removal of pesticides from potable water. The polymer-coated iron and iron oxide nanoparticles are made biocompatible, and their slow release makes them more effective and lasting. Their cytotoxicity against microbes under aerobic/anaerobic conditions has also been discussed. The magnetic moment of superparamagnetic iron oxide nanoparticles changes with their interaction with biomolecules as a consequence of which their size decreases. Their biological efficacy has been found to be dependent on the shape, size, and concentration of these nanoparticles.

Citing Articles

Platinum nanoparticles in cancer therapy: chemotherapeutic enhancement and ROS generation.

Faderin E, Iorkula T, Aworinde O, Awoyemi R, Awoyemi C, Acheampong E Med Oncol. 2025; 42(2):42.

PMID: 39789336 DOI: 10.1007/s12032-024-02598-w.

Banana fruit (Musa sp.) DNA-magnetite nanoparticles: Synthesis, characterization, and biocompatibility assays on normal and cancerous cells.

Arregui-Almeida D, Coronel M, Analuisa K, Bastidas-Caldes C, Guerrero S, Torres M PLoS One. 2024; 19(10):e0311927.

PMID: 39401205 PMC: 11472939. DOI: 10.1371/journal.pone.0311927.

Characterization and applications of iron oxide nanoparticles synthesized from Phyllanthus emblica fruit extract.

Fatima E, Arooj I, Shahid H, Aziz A PLoS One. 2024; 19(9):e0310728.

PMID: 39298494 PMC: 11412514. DOI: 10.1371/journal.pone.0310728.

Carbon quantum dots for the diagnosis and treatment of ophthalmic diseases.

Zhang X, Yang L, Wang F, Su Y Hum Cell. 2024; 37(5):1336-1346.

PMID: 39093514 DOI: 10.1007/s13577-024-01111-9.

Black seed assisted synthesis, characterization, free radical scavenging, antimicrobial and anti-inflammatory activity of iron oxide nanoparticles.

Shanmugam R, Tharani M, Abullais S, Patil S, Karobari M BMC Complement Med Ther. 2024; 24(1):241.

PMID: 38902620 PMC: 11191246. DOI: 10.1186/s12906-024-04552-9.

References

Zaitsev , Filimonov , Presnyakov , Gambino , Chu . Physical and Chemical Properties of Magnetite and Magnetite-Polymer Nanoparticles and Their Colloidal Dispersions. J Colloid Interface Sci. 1999; 212(1):49-57. DOI: 10.1006/jcis.1998.5993. View

Sipe J, Filippi M, Martino G, Furlan R, Rocca M, Rovaris M . Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents. Magn Reson Imaging. 1999; 17(10):1521-3. DOI: 10.1016/s0730-725x(99)00085-5. View

Lobel B, Eyal O, Kariv N, Katzir A . Temperature controlled CO(2) laser welding of soft tissues: urinary bladder welding in different animal models (rats, rabbits, and cats). Lasers Surg Med. 2000; 26(1):4-12. DOI: 10.1002/(sici)1096-9101(2000)26:1<4::aid-lsm3>3.0.co;2-j. View

Moore A, Marecos E, Bogdanov Jr A, Weissleder R . Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology. 2000; 214(2):568-74. DOI: 10.1148/radiology.214.2.r00fe19568. View

Alexiou C, Arnold W, Klein R, Parak F, Hulin P, Bergemann C . Locoregional cancer treatment with magnetic drug targeting. Cancer Res. 2000; 60(23):6641-8. View

Moghimi S, Hunter A, Murray J . Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001; 53(2):283-318. View

Zhang Y, Kohler N, Zhang M . Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials. 2002; 23(7):1553-61. DOI: 10.1016/s0142-9612(01)00267-8. View

Akerman M, Chan W, Laakkonen P, Bhatia S, Ruoslahti E . Nanocrystal targeting in vivo. Proc Natl Acad Sci U S A. 2002; 99(20):12617-21. PMC: 130509. DOI: 10.1073/pnas.152463399. View

Dumestre F, Chaudret B, Amiens C, Fromen M, Casanove M, Renaud P . Shape control of thermodynamically stable cobalt nanorods through organometallic chemistry. Angew Chem Int Ed Engl. 2002; 41(22):4286-9. DOI: 10.1002/1521-3773(20021115)41:22<4286::AID-ANIE4286>3.0.CO;2-M. View

10.

Kalish H, Arbab A, Miller B, Lewis B, Zywicke H, Bulte J . Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: relationship between relaxivities, electrostatic forces, and chemical composition. Magn Reson Med. 2003; 50(2):275-82. DOI: 10.1002/mrm.10556. View

11.

LaVan D, McGuire T, Langer R . Small-scale systems for in vivo drug delivery. Nat Biotechnol. 2003; 21(10):1184-91. DOI: 10.1038/nbt876. View

12.

Keum Y, Li Q . Reduction of nitroaromatic pesticides with zero-valent iron. Chemosphere. 2003; 54(3):255-63. DOI: 10.1016/j.chemosphere.2003.08.003. View

13.

Arbab A, Bashaw L, Miller B, Jordan E, Lewis B, Kalish H . Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology. 2003; 229(3):838-46. DOI: 10.1148/radiol.2293021215. View

14.

Tartaj P, Serna C . Synthesis of monodisperse superparamagnetic Fe/silica nanospherical composites. J Am Chem Soc. 2003; 125(51):15754-5. DOI: 10.1021/ja0380594. View

15.

Dumestre F, Chaudret B, Amiens C, Renaud P, Fejes P . Superlattices of iron nanocubes synthesized from Fe[N(SiMe3)2]2. Science. 2004; 303(5659):821-3. DOI: 10.1126/science.1092641. View

16.

Arbab A, Yocum G, Wilson L, Parwana A, Jordan E, Kalish H . Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol Imaging. 2004; 3(1):24-32. DOI: 10.1162/15353500200403190. View

17.

Gupta A, Berry C, Gupta M, Curtis A . Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis. IEEE Trans Nanobioscience. 2004; 2(4):255-61. DOI: 10.1109/tnb.2003.820279. View

18.

Gupta A, Wells S . Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nanobioscience. 2004; 3(1):66-73. DOI: 10.1109/tnb.2003.820277. View

19.

Hoet P, Bruske-Hohlfeld I, Salata O . Nanoparticles - known and unknown health risks. J Nanobiotechnology. 2004; 2(1):12. PMC: 544578. DOI: 10.1186/1477-3155-2-12. View

20.

Gupta A, Gupta M . Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005; 26(18):3995-4021. DOI: 10.1016/j.biomaterials.2004.10.012. View